ANTX financials
AN2 Therapeutics (ANTX) financials: revenue, profit and margins by year and quarter, the balance sheet and cash flow.
ANTX income statement, yearly
| Year | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2025 | – | – | -$38.11M | -$35.17M | -1.16 |
| 2024 | – | – | -$56.79M | -$51.32M | -1.72 |
| 2023 | – | – | -$69.64M | -$64.73M | -2.74 |
| 2022 | – | – | -$42.26M | -$42.78M | -2.79 |
| 2021 | – | – | -$21.57M | -$28.06M | -10.64 |